Wockhardt

According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt for…

WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP Wockhardt…

The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt's Chikalthana plant at…

The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price regulator…

EBIDTA was at Rs 201 crore

Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt's recall was under class-II…

EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The…

International business contributed 72 per cent of the total revenues during the FY14-15

Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana…

Wockhardt said this was a measure of preparedness and abundant precaution and there is no evidence of risk to patient safety from…